SATURDAY May 31, 2014, 2014 — A combination of two new pills may nearly double the length of survival for patients with recurrent ovarian cancer, according to preliminary clinical trial results. The therapy combines the drugs olaparib and cediranib. It provided nearly 18 months of…
Source:Pair of Pills Shows Promise for Recurrent Ovarian Cancer
Saturday, May 31, 2014
Pair of Pills Shows Promise for Recurrent Ovarian Cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment